This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Roger H. Unger, MD; Anna M. Eisentraut

Arch Intern Med. 1969;123(3):261-266.

Abstract
Evidence for an entero-insular axis is based upon studies showing that amino acids as well as glucose cause a greater and earlier release of islet cell hormones when administered via the gastrointestinal tract than occurs with comparable elevations in the plasma concentrations of the nutrients given intravenously. The ability of several gastrointestinal hormones to elicit immediate augmentation of insulin and glucagon secretion has been established. Gastrin, secretin, and pancreozymin in dogs all produce an immediate rise of insulin to a peak one minute after injection, but the response to gastrin is quantitatively trivial, while that to secretin is modest. However, pancreozymin elicits substantial release of both insulin and glucagon, and augments the insulinogenic and glucagonogenic effects of amino acids. The physiologic implications of such studies are considered.

Author Affiliations
Dallas

From the Department of Internal Medicine, the University of Texas Southwestern Medical School at Dallas, and; the Veterans Administration Hospital, Dallas.

Footnotes
Received for publication Oct 18, 1968; accepted Nov 26.

Reprint requests to Department of Internal Medicine, Veterans Administration Hospital, Dallas 75216 (Dr. Unger).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Expression of glucose-dependent insulinotropic polypeptide in the zebrafish
Musson et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;297:R1803-R1812.
ABSTRACT | FULL TEXT  

Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus
Vetter et al.
ANN INTERN MED 2009;150:94-103.
ABSTRACT | FULL TEXT  

The augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice
Ahren et al.
J Endocrinol 2008;197:181-187.
ABSTRACT | FULL TEXT  

Sitagliptin -- enhancing incretin action
Campbell and Day
British Journal of Diabetes & Vascular Disease 2007;7:134-139.
ABSTRACT  

Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects
Meier et al.
Diabetes 2005;54:2212-2218.
ABSTRACT | FULL TEXT  

Review: Development and therapeutic potential of incretin hormone analogues for type 2 diabetes
Green et al.
British Journal of Diabetes & Vascular Disease 2005;5:134-140.
ABSTRACT  

First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Caumo and Luzi
Am. J. Physiol. Endocrinol. Metab. 2004;287:E371-E385.
ABSTRACT | FULL TEXT  

The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes
Harder et al.
Diabetes Care 2004;27:1915-1921.
ABSTRACT | FULL TEXT  

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
Holst and Gromada
Am. J. Physiol. Endocrinol. Metab. 2004;287:E199-E206.
ABSTRACT | FULL TEXT  

Elevated Plasma Glucose-Dependent Insulinotropic Polypeptide Associates With Hyperinsulinemia in Impaired Glucose Tolerance
Theodorakis et al.
Diabetes Care 2004;27:1692-1698.
ABSTRACT | FULL TEXT  

Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine
Johnston et al.
Am. J. Clin. Nutr. 2003;78:728-733.
ABSTRACT | FULL TEXT  

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis
Pamir et al.
Am. J. Physiol. Endocrinol. Metab. 2003;284:E931-E939.
ABSTRACT | FULL TEXT  

Elevated Glucagon-Like Peptide-1-(7-36)-Amide, but Not Glucose, Associated with Hyperinsulinemic Compensation for Fat Feeding
Van Citters et al.
J. Clin. Endocrinol. Metab. 2002;87:5191-5198.
ABSTRACT | FULL TEXT  

Long-Term Treatment With the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and {beta}-Cell Glucose Responsiveness in VDF (fa/fa) Zucker Rats
Pospisilik et al.
Diabetes 2002;51:943-950.
ABSTRACT | FULL TEXT  

Novel gastroinsular axis involving a gastric transmural glucose flux and vagal mediation
Nakagawa et al.
Am. J. Physiol. Endocrinol. Metab. 2001;281:E304-E314.
ABSTRACT | FULL TEXT  

Glucagon-Like Peptide-1, But Not Glucose-Dependent Insulinotropic Peptide, Regulates Fasting Glycemia and Nonenteral Glucose Clearance in Mice
Baggio et al.
Endocrinology 2000;141:3703-3709.
ABSTRACT | FULL TEXT  

Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist
Lewis et al.
Endocrinology 2000;141:3710-3716.
ABSTRACT | FULL TEXT  

Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish
Mojsov
Integr. Comp. Biol. 2000;40:246-258.
ABSTRACT | FULL TEXT  

Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
Miyawaki et al.
Proc. Natl. Acad. Sci. USA 1999;96:14843-14847.
ABSTRACT | FULL TEXT  

The Glucagon-Like Peptides
Kieffer and Francis Habener
Endocr. Rev. 1999;20:876-913.
ABSTRACT | FULL TEXT